0001161697-17-000492.txt : 20171113 0001161697-17-000492.hdr.sgml : 20171110 20171113162057 ACCESSION NUMBER: 0001161697-17-000492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171109 FILED AS OF DATE: 20171113 DATE AS OF CHANGE: 20171113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tierney David S CENTRAL INDEX KEY: 0001292636 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 171196168 MAIL ADDRESS: STREET 1: C/O ABLE LABORATORIES, INC. STREET 2: 6 HOLLYWOOD COURT, CN 1013 CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1250 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1250 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 11-09-2017 X0306 4 2017-11-09 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001292636 Tierney David S 355 ALHAMBRA CIRCLE, SUITE 1250 CORAL GABLES FL 33134 1 0 0 0 Common stock, par value $0.001 per share 2017-11-09 4 M 0 50000 0.47 A 313401 D Common stock, par value $0.001 per share 2017-11-09 4 F 0 7860 D 305541 D Options to purchase common stock 0.47 2017-11-09 4 M 0 50000 0 D 2012-12-12 2017-12-12 Common Stock 50000 145000 D Holder exercised 50,000 options at $0.47 per share via cashless exercise and was issued 42,140 shares based on the November 8, 2017 closing price of $2.99 per share. /s/ David S. Tierney 2017-11-09